Cybin Inc. Common Stock
HELP
Rank in Stocks
#11287
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$9.37
Last synced: 2026-11-09
Market Cap
$580.79M
Change (1 day)
4.58%
Change (1 year)
-
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cybin Inc. Common Stock (HELP)
Category
Healthcare
EPS for Cybin Inc. Common Stock (HELP)
EPS as of June 2026 TTM: $-5.51
According to Cybin Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-5.51. At the end of 2025 the company had an EPS of $-3.88, a decrease compared to its 2024 EPS of $-2.89.
EPS history for Cybin Inc. Common Stock from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-5.51 | 42.01% |
| 2025 | $-3.88 | 34.43% |
| 2024 | $-2.89 | -59.83% |
| 2023 | $-7.19 | -41.46% |
| 2022 | $-12.29 | 26.14% |
| 2021 | $-9.74 | 826.76% |
| 2020 | $-1.05 | 395.33% |
| 2019 | $-0.21 | -59.95% |
| 2018 | $-0.53 | 89.39% |
| 2017 | $-0.28 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -384.21% |
US
|
|
| $-7.07 | 28.31% |
US
|
|
| $-5.29 | -3.99% |
AU
|
|
| $12.88 | -333.76% |
BE
|
|
| $21.56 | -491.29% |
NL
|
Questions about Cybin Inc. Common Stock's earnings per share (EPS)
What is Cybin Inc. Common Stock's earnings per share (EPS)?
Cybin Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-5.51, as of Jun 2026.
What was Cybin Inc. Common Stock's earnings per share (EPS) in 2025?
In 2025, Cybin Inc. Common Stock's earnings per share (EPS) was $-3.88, compared with $-2.89 in 2024.
How has Cybin Inc. Common Stock's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cybin Inc. Common Stock's earnings per share (EPS) was highest in 2020 ($-1.05) and lowest in 2022 ($-12.29).
How does Cybin Inc. Common Stock's earnings per share (EPS) compare with similar companies?
Cybin Inc. Common Stock's earnings per share (EPS) ($-5.51) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.